Home
/
/
SARS-CoV-2 Treatment & Prevention Approaches

SARS-CoV-2 Treatment & Prevention Approaches

There have been steroid trials where patients were using steroids to reduce inflammation of the joints. For the most topically tadalafil stada 5 mg filmtabletten part, no, clomid is not a birth control pill. Clomid order without prescription in new haven, ct.

Your healthcare provider can diagnose any health problems you may have. The pharmacy canada will not only give cialis sicher online kaufen you the best price. Possible liver problems have also been reported with doses as low as 20mg.

More info about license types

Free of 19 % VAT (except in Germany and also in the European Union without valid intl. VAT no), delivery costs do not apply.

You can also order this product via email or fax, please download the Order Form

Publisher: La Merie Publishing
Pages: 17
Format: PDF
Product Line: Competitor Analysis
Product Code: LMCA0181
Release Date: March of 2020
Categories: ,
Ask a question
Loading...

Competitor Analysis: SARS-CoV-2 Treatment & Prevention Approaches

This Competitive Intelligence report about SARS-CoV-2 Treatment & Prevention Approaches describes the landscape of industry-driven approaches to evaluate existing, discover novel treatments and vaccines for COVID-19.

COVID-19 is caused by SARS-CoV-2, which belongs to a group of viruses called coronaviruses that attack the respiratory system. There is currently no licensed vaccine, treatment or cure for COVID-19. Industry alone or collaboration with govermnent agencies or non-governmental organizations (NGOs) have started to searh for safe and effective treatments and vaccines to fight the novel 2019 coronavirus (2019-nCoV or SARS-CoV-2) causing COVID-19 disease.

This report includes a compilation of industry-driven projects in research and development of treatments and vaccines for COVID-19. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies. The information is provided in a tabular format and fully referenced.

Related products

Single User License:

This license allows for use of a report by one named person, explicitly confirmed at point of sale

Departmental License:

This license allows for use of a report by members of the same Dept within the same enterprise location or of the same international Project Group.

Site License:

This license allows for use of a report by an unlimited number of people within the same enterprise location.

Global Site License:

This license allows for use of a report by an unlimited number of people within the same enterprise worldwide.

Contacts

Custom Support & Sale:
+49-7934-6839 668

Mon–Fri: 10:00 am –5:00 pm GMT+01

Error: Contact form not found.